Can 4D bioprinting revolutionize drug development?

Expert Opin Drug Discov. 2019 Oct;14(10):953-956. doi: 10.1080/17460441.2019.1636781. Epub 2019 Jul 8.

Izeia Lukin^{1

2}, Saioa Musquiz^{1

2}, Itsasne Erezuma^{1

2}, Taleb H Al-Tel³, Nasim Golafshan⁴, Alireza Dolatshahi-Pirouz^{5

6}, Gorka Orive^{1

2

7

8}

¹ NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country UPV/EHU , Vitoria-Gasteiz , Spain.
² Biomedical Research Networking Centre in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) , Vitoria-Gasteiz , Spain.
³ Sharjah Institute for Medical Research and College of Pharmacy, University of Sharjah , Sharjah , United Arab Emirates.
⁴ Department of Orthopedics, University Medical Center, Utrecht University , Utrecht , The Netherlands.
⁵ Department of Health Technology, Center for Intestinal Absorption and Transport of Biopharmaceuticals, Technical University of Denmark , Denmark.
⁶ Department of Regenerative Biomaterials, Radboud University Medical Center , Nijmegen , The Netherlands.
⁷ University Institute for Regenerative Medicine and Oral Implantology - UIRMI (UPV/EHU-Fundación Eduardo Anitua) , Vitoria , Spain.
⁸ Singapore Eye Research Institute, The Academia , Singapore.

No abstract available

Keywords: 4D bioprinting; cells; drug delivery; smart materials; stimuli; tissue engineering.

Publication types